Ravelcare Limited – IPO
Ravelcare Limited – IPO Details
| IPO Date | December 1, 2025 to December 3, 2025 |
| Listing Date | December 8, 2025 |
| Face Value | ₹ 10 / Share |
| Price Band | ₹ 123 to ₹ 130 / Share |
| Lot Size | 1000 Shares |
| Total Issue Size | 18,54,000 shares (Aggregating up to ₹24.10 Cr) |
| Fresh Issue | |
| Offer for Sale | |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share holding pre issue | 50,05,000 shares |
| Share holding post issue | 68,59,000 shares |
| Market Maker portion |
Ravelcare Limited Timeline (Tentative Schedule)
Ravelcare Limited IPO opens on December 1, 2025, and closes on December 3, 2025.
| IPO Open Date | December 1, 2025 |
| IPO Close Date | December 3, 2025 |
| Basis of Allotment | December 4, 2025 |
| Initiation of Refunds | December 5, 2025 |
| Credit of Shares to Demat | December 5, 2025 |
| Listing Date | December 8, 2025 |
| Cut-off time for UPI mandate confirmation | December 3, 2025 |
Ravelcare Limited IPO Lot Size
Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | Rs.260,000 |
| Retail (Max) | 2 | 2,000 | Rs.260,000 |
| S-HNI (Min) | 3 | 3,000 | Rs.390,000 |
| S-HNI (Max) | 7 | 7,000 | Rs.910,000 |
| B-HNI (Min) | 8 | 8,000 | Rs.1,040,000 |
| HNI (Min) |
Ravelcare Limited IPO Promoter Holding
| Share Holding Pre Issue | 99.96% |
| Share Holding Post Issue |
Ravelcare Limited IPO Reservation
Ravelcare IPO offers a total of 18,54,000 shares. Out of which 8,76,000 (47.25%) allocated to QIB, 3,51,000 (18.93%) allocated to QIB (Ex- Anchor), 2,64,000 (14.24%) allocated to NII, 6,20,000 (33.44%) allocated to RII, and 5,25,000 (28.32%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | 94,000 (5.07%) |
|
| Other Shares Offered | |
|
| QIB Shares Offered | 8,76,000 (47.25%) |
|
| NII (HNI) Shares Offered | 2,64,000 (14.24%) |
|
| bNII > ₹10L | |
|
| sNII < ₹10L | |
|
| Retail Shares Offered | 6,20,000 (33.44%) |
|
| Employee Shares Offered | |
|
| Total Shares Offered | 18,54,000 (100.00%) |
Ravelcare Limited IPO Anchor Investors Details
| Bid Date | 2025-11-28 |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | 6.83 |
| Anchor lock-in period end date for 50% shares (30 Days) | January 3, 2026 |
| Anchor lock-in period end date for remaining shares (90 Days) | March 4, 2026 |
About Ravelcare Limited
Incorporated in November 2018, Ravelcare Ltd. is a digital-first beauty and personal care (BPC) brand offering a comprehensive range of haircare, skincare, bodycare, and scalp care products tailored to individual needs.
The company operates primarily through its website and online marketplaces such as Amazon, Flipkart, and Myntra, along with quick commerce platforms like Blinkit. In FY 2024–25, Ravelcare expanded its presence internationally, catering to customers in the UAE, Australia, Canada, Germany, the USA, and Saudi Arabia.
To ensure supply chain reliability and timely product delivery, the company manages logistics and warehousing operations across central Indian states. Additionally, Ravelcare plans to set up its integrated manufacturing facility in Mauje-Peth, Amravati, Maharashtra, with a proposed installed capacity of 1,050 TPA. This facility will house R&D, manufacturing, packaging, warehousing, and distribution under one roof.
Product Offerings
Ravelcare’s portfolio spans four key segments:
Haircare: Includes shampoos, conditioners, masks, oils, and styling products tailored to concerns like hair fall, frizz, and damage from chemical treatments. Products are customized via digital consultations and are sold through online platforms.
Skincare comprises cleansers, serums, moisturisers, sunscreens, and treatments for acne, dryness, pigmentation, and sensitivity. Customisation is based on digital skin assessments.
Bodycare: Offers body washes and lotions designed for hydration, cleansing, and skin barrier repair, addressing conditions like dryness and sensitivity.
Scalp Care: Features targeted treatments such as anti-dandruff tonics, hair growth serums, and approved hair fall control ampoules for issues like dryness, flaking, and buildup.
As of June 30, 2025, the company employed 25 professionals across departments.
Competitive Strengths
Wide and Diversified Customer Base: The company serves a broad domestic and international customer base through a distributed warehousing model and third-party logistics, ensuring fast and reliable delivery.
Digital-First Distribution: Operating primarily through D2C channels, Ravelcare reduces dependency on intermediaries and controls the entire customer journey—from discovery to delivery—allowing competitive pricing and consistent service.
Customer-Centric Approach: Ravelcare builds strong relationships via a personalised digital consultation process, enabling the brand to understand individual needs and provide tailored product recommendations. Word-of-mouth from satisfied customers drives organic growth.
Innovation-Led Product Development: The company continuously innovates based on customer feedback and digital interactions. Product development includes concept ideation, formulation, regulatory compliance, testing, and market positioning, driven by structured consumer insights.
With its focus on personalisation, international expansion, and digital innovation, Ravelcare Ltd. positions itself as a modern, data-driven beauty and personal care brand addressing the evolving needs of customers globally.
Key Performance Indicator
KPI as of Mon, Mar 31, 2025.
| KPI | Values |
|---|---|
| ROE | 68.04% |
| ROCE | 68.32% |
| Debt/Equity | |
| RoNW | 50.77% |
| P/BV | 6.29 |
| PAT Margin (%) | 21.01% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 10.50 | 9.32 |
| P/E (x) | 12.38 | 13.95 |
Note:
- The Pre IPO EPS is calculated based on Pre issue shareholding as on the date of RHP and the latest FY earnings as of March 31, 2025, that are available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of September 30, 2025, which is available in RHP.
Objects of the Issue (Ravelcare Limited IPO Objectives)
Ravelcare Limited Contact Details
Ravelcare Ltd. Off-126, Neo Corporate Plaza Cabin B, Ramchandra Lane Extension Malad, Mumbai Malad, Maharashtra, 400064 Phone: +91 87792 06822 Email: [email protected] Website: http://www.ravelcare.com/ |
Ravelcare Limited IPO Registrar
Kfin Technologies Ltd. Phone: 04067162222, 04079611000 Email: [email protected] Website: https://ipostatus.kfintech.com/ |